Efficacy and Safety of Erenumab in the Preventive and Therapeutic Treatment of Patients Suffering From Migraine.

Erenumab is a new medication aimed at preventing migraines. It works by blocking a specific receptor involved in migraine attacks. This study reviewed six clinical trials with 3,403 participants. Researchers looked at how effective and safe erenumab is for migraine patients. The main goal was to see if patients had at least a 50% reduction in migraine days after 12 weeks. Secondary goals included tracking the total number of migraine days and any side effects. Results showed that erenumab significantly reduced the number of migraine days for many patients. Overall, it was found to be safe, with manageable side effects. This research highlights the potential of erenumab as a valuable treatment option for people suffering from migraines. It could improve their quality of life and reduce the burden of this common neurological disorder. Clinical relevance: This research supports erenumab as an effective preventive treatment for migraines, offering hope for improved patient outcomes.